Clinical Equipoise in the Management of Patients With Femoroacetabular Impingement Syndrome and Concomitant Tönnis Grade 2 Hip Osteoarthritis or Greater: An International Expert-Panel Delphi Study
Octavian Andronic,Victor Lu,Leica Sarah Claydon-Mueller,Rachael Cubberley,International FAIS Expert Panel,,Vikas Khanduja,Anil S Ranawat,Michael Wettstein,John O'Donnell,Tony Andrade,Allston J Stubbs,Kristian Thorborg,Nicolas Bonin,Derek Ochiai,Per Hoelmich,Theodora Papadopoulou,Soshi Uchida,Qingfeng Yin,Parminder J Singh,Oliver Marin-Pena,Michael Voight,Marcelo Cavalheiro Queiroz,Julie Sandell Jacobsen,Josip Cakic,Joanne L Kemp,Filippo Randelli,Etienne L Belzile,Dinshaw Pardiwala,Baris Kocaoglu,Amir Takla,Athanasios Papavasiliou
DOI: https://doi.org/10.1016/j.arthro.2023.12.010
Abstract:Purpose: To gather global-expert opinion on the management of patients with femoroacetabular impingement syndrome (FAIS) and Tönnis grade 2 hip osteoarthritis (OA) or greater. Methods: An internet-based modified Delphi methodology was used via an online platform (Online Surveys) using the CREDES (Conducting and Reporting Delphi Studies) guidelines. The expert panel comprised 27 members from 18 countries: 21 orthopaedic surgeons (78%), 5 physiotherapists (18%), and 1 dual orthopaedic surgeon-sport and exercise medicine physician (4%). Comments and suggestions were collected during each round, and amendments were performed for the subsequent round. Between each pair of rounds, the steering panel provided the experts with a summary of results and amendments. Consensus was set a priori as minimum agreement of 80%. Results: Complete participation (100%) was achieved in all 4 rounds. A final list of 10 consensus statements was formulated. The experts agreed that there is no single superior management strategy for FAIS with Tönnis grade 2 OA and that Tönnis grade 3 OA and the presence of bilateral cartilage defects (acetabular and femoral) is a contraindication for hip preservation surgery. Nonoperative management should include activity modification and physiotherapy with hip-specific strengthening, lumbo-pelvic mobility training, and core strengthening. There was no consensus on the need for 3-dimensional imaging for initial quantification of joint degeneration. Conclusions: There is clinical equipoise in terms of the best management strategy for patients with FAIS and Tönnis grade 2 OA, and therefore, there is an urgent need to perform a randomized controlled trial for this cohort of patients to ascertian the best management strategy. Level of evidence: Level V, expert opinion.